Abstract
Sensorineural hearing loss due to quinine therapy for malaria has frequently been mentioned in the literature but has not been a subject of research during the last decades. The global spreading of chloroquine-resistant falciparum malaria brings about an increasing use of quinine. The ototoxicity of quinine can accurately be studied with ultrahigh frequency audiometry (up to 20 kHz). The case of a 29-year-old man suffering from falciparum malaria disease who get a reversible hearing loss from quinine therapy is presented.
| Original language | English |
|---|---|
| Pages (from-to) | 65-68 |
| Journal | ORL; journal for oto-rhino-laryngology and its related specialties |
| Volume | 52 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1990 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Quinine-induced hearing loss'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver